Is MUC1 a viable therapeutic target for patients with the asbestos-induced tumour malignant mesothelioma? [ 2010 - 2013 ]

Also known as: New targets for an asbestos-induced cancer

Research Grant

[Cite as]

Researchers: Prof Jenette Creaney (Principal investigator) ,  Dr Amanda Segal Prof Anna Nowak Prof Bruce Robinson

Brief description The deadly asbestos-induced cancer mesothelioma is continuing to kill tens of thousands of people each year. Most patients are diagnosed with advanced disease. We are investigating the use of a specific marker, called MUC1, to improve mesothelioma diagnosis. Improved diagnosis will reduce the time taken to commence treatment. It will also reduce hospital costs and the number of surgical procedures a patients must undergo.

Funding Amount $AUD 465,068.51

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Viewed: [[ro.stat.viewed]]